4Mulliken JB, Glowacki. Hemangiomas and vascular malformations in infants and children:a classification based on endothelial characteristics. Plast Reconstr Surg, 1982,69 : 412.
5Bortoshesky LE. Corlicosteroid treatment of cutaneous hmangiomas:how effective? a report on 24 children. Clin Pediatr, 1978,17:625.
6Glowacki J, Mulliken JB. Mast ceLLs in hemangiomas and vascular malformation.Pediatres, 1982,70:48.
7Grooke ST. Antitumor antibiotica actionmycin D.bleormycin mitomycin C and other antibiotics. In:Pinedo HM. ed. Cancer Chermothearpy. Amsterdam: Excepta Meclica, 1981,95.
8Steighner RJ ,Povirk LF. Bleomycin-induced DNA lesion atmutslional hot spots: Implications for the mechnism of double-strand cleavage. Proe Nail Aeed Sci USA, 1990,87:8350.
5Buckmiller LM, Richter GT, Suen JY. Diagnosis and managementof hemangiomas and vascular malformations of the head andneck[J], Oral Dis, 2010, 16(5): 405-418. DOI: 10.1111/j.l601-0825.2010.01661.
6Jia WZ, Hua MM, Ling Z. et al. Guidelines for the treatment ofhead and neck venous malformations[J]. Int J Clin Exp Med, 2013,6(5): 377-389.
7Takahshi K, Mulliken JB, Kozakewich HP, et al. Cellular markersthat distinguish the phases of hemangioma during infancy andchildhood[J]. J Clin Invest. 1994. 93(6): 2357-2364. DOI: 10.1172/JCI117241.
8Edyta S, Tomasz N, Ewa IS, et al. Is hepatotropic contrastenhanced MR a more effective method in differential diagnosis ofhemangioma than multi-phase CT and unenhanced MR[J]. BMCGastroenterol, 2011,11(19): 43-53. DOI: 10.1186/1471-230X-11-43.
9Blaise S, Charavin CM, Riom H, et al. Treatment of Iow-flowvascular malformations by ultrasound-guided sclerotherapywith polidocanol foam: 24 cases and literature review[J]. EurJ Vase Endovasc Surg, 2011, 41(3): 412-417. DOI: 10.1016/j.ejvs.2010.10.009.
